Literature DB >> 10809904

rhIGF-I/IGFBP-3 complex, but not free rhIGF-I, supports muscle protein biosynthesis in rats during semistarvation.

E Svanberg1, C Ohlsson, S R Kimball, K Lundholm.   

Abstract

BACKGROUND: The aim of this study was to evaluate the effect of insulin like growth factor-I (rhIGF-I) in complex with binding protein 3 (IGFBP 3) compared to the effect of free IGF-I on muscle protein biosynthesis in undernourished animals.
METHODS: Three groups of female Sprague-Dawley rats (200 g) were initially semi-starved for 3 days and then treated with saline (controls), rhIGF-I (1 microg g-1) or equimolar amounts of rhIGF-I/rhIGFBP-3 complex (5 microg g-1) i.v. twice daily for 3 days during continuous semistarvation. Protein metabolism in hind limb skeletal muscle was studied by incorporation of L-[14C-U]phenylalanine into proteins, western blot determination of translation initiation factors involved in the binding of the 40S ribosomal subunit to mRNA, and quantification of mRNA content for IGF-I, IGF-IR and GH-R. Plasma measurements of insulin, IGF-I and amino acids were also performed.
RESULTS: rhIGF-I/rhIGFBP-3, but not rhIGF-I alone, stimulated protein synthesis by 177 +/- 26% (P </= 0.05) in semi-starved rats. This stimulation was associated with dissociation of the 4E-BP1. eIF-4E complex, implicating increased binding of the 40S ribosomal subunit to mRNA, and hence increased initiation of protein synthesis in these animals. Muscle content of IGF-I mRNA was reduced in semi-starved animals, whereas IGF-I receptor mRNA was unaltered despite food restriction. Plasma concentration of IGF-I was 20% (P </= 0.05) higher in rhIGF-I/rhIGFBP-3 treated animals as compared to rats treated with saline or free IGF-I. Plasma concentrations of amino acids were increased in rhIGF-I/rhIGFBP-3 treated animals (P </= 0.05 vs. semi-starved controls).
CONCLUSION: rhIGF-I/rhIGFBP-3 (SomatoKine) was a significant stimulator of muscle protein synthesis in chronically semi-starved animals whereas IGF-I alone failed to increase protein synthesis during the same experimental conditions. This stimulation was because of increased initiation of translation, likely induced by more physiologic concentrations/kinetics of plasma IGF-I and amino acids following rhIGF-I/rhIGFBP-3 treatment, compared to IGF-I in its free form.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10809904     DOI: 10.1046/j.1365-2362.2000.00652.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  7 in total

1.  The impact of insulin-like growth factor-1 on the pattern of cardiac elongation factor-2 variants in a model of overload.

Authors:  Doris Jäger; Ursula Müller-Werdan; Klaus Pönicke; Jürgen Holtz; Karl Werdan; Sylvana P Müller
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

Review 2.  New drugs for the anorexia-cachexia syndrome.

Authors:  Mellar P Davis
Journal:  Curr Oncol Rep       Date:  2002-05       Impact factor: 5.075

3.  Initiation of muscle protein synthesis was unrelated to simultaneously upregulated local production of IGF-1 by amino acids in non-proliferating L6 muscle cells.

Authors:  Britt-Marie Iresjö; Lisa Diep; Kent Lundholm
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

4.  Local insulin-like growth factor I prevents sepsis-induced muscle atrophy.

Authors:  Gerald Nystrom; Anne Pruznak; Danuta Huber; Robert A Frost; Charles H Lang
Journal:  Metabolism       Date:  2009-06       Impact factor: 8.694

5.  Impaired expression of insulin-like growth factor-1 system in skeletal muscle of amyotrophic lateral sclerosis patients.

Authors:  Christian Lunetta; Massimo Serafini; Alessandro Prelle; Paolo Magni; Elena Dozio; Massimiliano Ruscica; Jenny Sassone; Clarissa Colciago; Maurizio Moggio; Massimo Corbo; Vincenzo Silani
Journal:  Muscle Nerve       Date:  2012-02       Impact factor: 3.217

6.  Liver-derived endocrine IGF-I is not critical for activation of skeletal muscle protein synthesis following oral feeding.

Authors:  Britt-Marie Iresjö; Johan Svensson; Claes Ohlsson; Kent Lundholm
Journal:  BMC Physiol       Date:  2013-05-08

7.  The use of anabolic agents in catabolic states.

Authors:  Robert Demling
Journal:  J Burns Wounds       Date:  2007-02-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.